Article
Genetic control of bone mass.
Molecular and cellular endocrinology - 5 Sept 2016
Boudin Eveline, Fijalkowski Igor, Hendrickx Gretl, Van Hul Wim
Abstract excerpt
Bone mineral density (BMD) is a quantitative traits used as a surrogate phenotype for the diagnosis of osteoporosis, a common metabolic disorder characterized by increased fracture risk as a result of a decreased bone mass and deterioration of the microarchitecture of the bone. Normal variation in BMD is determined by both environmental and genetic factors. According to heritability studies, 50-85% of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
